跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 113 条关于
“Madrigal”
全部
113
临床试验
63
药物
1
机构
3
资讯
46
去年
Madrigal Pharmaceuticals Reports Third-Quarter 2024 - GlobeNewswire
去年
Madrigal Pharmaceuticals Reports Strong Rezdiffra Launch and Advancement of NASH Cirrhosis Study
去年
Madrigal Pharmaceuticals' Rezdiffra Sees Strong Uptake and Expansion Potential in MASH Treatment
去年
Madrigal Pharmaceuticals Reports Strong Rezdiffra Launch and Provides Corporate Updates
去年
Madrigal Pharmaceuticals Reports Strong Rezdiffra Launch and Clinical Progress in NASH/MASH
去年
Madrigal Pharmaceuticals Reports Strong Rezdiffra Launch and Clinical Progress in NASH/MASH
去年
Madrigal Pharmaceuticals Reports Positive Q3 2024 Results and Advances NASH/MASH Programs
去年
Regeneron Faces Eylea Uncertainty; Madrigal's Rezdiffra Exceeds Expectations
去年
Madrigal Pharmaceuticals Advances in NASH Treatment with Resmetirom Phase 3 Trials
去年
Madrigal's MASH Drug Rezdiffra Sees Strong Launch, Compass Pathways Lays Off Staff
第 1 页,共 5 页
上一页
下一页